Procter & Gamble Company (The) $PG Shares Sold by James Investment Research Inc.

Key Points

• James Investment Research trimmed its stake in Procter & Gamble by 23.7% in Q4, selling 18,763 shares and leaving it with 60,377 shares valued at $8.65 million (0.9% of the fund and its 24th largest holding).
• P&G beat EPS and set FY‑2026 guidance: Q3 adjusted EPS was $1.59 (vs. $1.56 est.), revenue rose 7.4% year‑over‑year to $21.24 billion, management set FY‑2026 EPS guidance of $6.83–$7.09, and the company raised its quarterly dividend to $1.0885 (annualized $4.35, ~2.9% yield).
• Significant insider selling has occurred recently — CEO Gary Coombe sold 36,093 shares and another senior insider sold 12,827, with insiders disposing of 252,715 shares (~$40.97M) in the past 90 days while insiders now own 0.20% of the stock.

James Investment Research Inc. trimmed its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 23.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 60,377 shares of the company's stock after selling 18,763 shares during the quarter. Procter & Gamble makes up 0.9% of James Investment Research Inc.'s portfolio, making the stock its 24th biggest holding. James Investment Research Inc.'s holdings in Procter & Gamble were worth $8,653,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Halbert Hargrove Global Advisors LLC purchased a new stake in Procter & Gamble during the 3rd quarter worth about $25,000. Maseco LLP purchased a new position in Procter & Gamble in the 4th quarter valued at about $28,000. Saranac Partners Ltd purchased a new position in Procter & Gamble in the 3rd quarter valued at about $30,000. Corundum Trust Company INC acquired a new stake in shares of Procter & Gamble during the 3rd quarter worth about $32,000. Finally, Caitlin John LLC purchased a new stake in shares of Procter & Gamble during the third quarter worth about $34,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on PG shares. TD Cowen cut their price objective on shares of Procter & Gamble from $156.00 to $142.00 and set a "hold" rating for the company in a research report on Wednesday, April 1st. Raymond James Financial decreased their target price on shares of Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 14th. The Goldman Sachs Group cut their price target on Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a report on Wednesday, April 8th. Rothschild & Co Redburn increased their price target on Procter & Gamble from $155.00 to $157.00 and gave the stock a "neutral" rating in a research note on Friday, January 23rd. Finally, BNP Paribas Exane decreased their price objective on Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating on the stock in a report on Thursday. Ten research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus target price of $160.41.

Procter & Gamble Trading Down 0.0%

Shares of PG stock opened at $148.11 on Monday. The firm's 50-day simple moving average is $150.32 and its 200-day simple moving average is $148.66. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $170.99. The firm has a market cap of $344.21 billion, a P/E ratio of 21.65, a PEG ratio of 5.72 and a beta of 0.41.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 31.88%. The firm had revenue of $21.24 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same period in the previous year, the firm earned $1.54 earnings per share. Procter & Gamble's revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts forecast that Procter & Gamble Company will post 6.95 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 24th will be paid a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. Procter & Gamble's dividend payout ratio is presently 64.44%.

Insiders Place Their Bets

In related news, CEO Gary A. Coombe sold 36,093 shares of Procter & Gamble stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $162.33, for a total value of $5,858,976.69. Following the transaction, the chief executive officer owned 34,994 shares in the company, valued at approximately $5,680,576.02. This trade represents a 50.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 12,827 shares of the business's stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total value of $2,056,296.37. Following the sale, the insider directly owned 12,639 shares of the company's stock, valued at approximately $2,026,158.09. This trade represents a 50.37% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 252,715 shares of company stock worth $40,966,904. Corporate insiders own 0.20% of the company's stock.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Q3 earnings and core metrics beat expectations — adjusted EPS topped consensus and net sales/organic sales rose year‑over‑year, showing volume-led growth that suggests improving consumer demand. Business Wire: Q3 Results
• Positive Sentiment: Beauty and premium brands outperformed (e.g., SK‑II growth), supporting higher-margin mix and contributing to market‑share gains cited by management. Reuters: Beauty Demand Strength
• Positive Sentiment: Unusually heavy call-option buying and positive analyst notes pre/post‑release amplified buying momentum, signaling increased bullish positioning from traders and some brokers. (Options volume spike reported in market coverage.)
• Neutral Sentiment: Management reiterated fiscal‑2026 guidance (EPS range ~6.83–7.09) and maintained its outlook — that gives reassurance on the plan but leaves upside capped until guidance is raised. P&G Press Release / Slides
• Negative Sentiment: P&G disclosed a roughly $150 million hit to annual profits from Middle East disruptions (higher energy/logistics/input costs), a tangible near‑term headwind that pressure margins and could constrain FY earnings. Benzinga: $150M Hit
• Negative Sentiment: Some sell‑side desks trimmed price targets and highlighted input-cost risks (resin, energy), which tempers upside and keeps valuation scrutiny on the stock. MarketScreener: PT Adjustments

Procter & Gamble Company Profile

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.